Abstract
Introduction: Diabetic nephropathy is characterized by hypertension, progressive albuminuria, glomerulosclerosis and declines in glomerular filtration rate leading to end stage renal disease. Although the pathogenesis of diabetic nephropathy is not fully understood, current treatment of the patients with diabetic nephropathy is mainly based upon the control of hyperglycaemia and management of blood pressures.
Background: Several drugs, which are originally developed for hypertension therapy, have been adopted for stabilization of renal function in diabetic nephropathy. In this review, we first discussed the relationships between diabetic nephropathy and hypertension particularly in the renin-angiotensinaldosterone system. We then summarized chemical structures, pharmacological characteristics and clinical studies of the common drugs used for treatment of diabetic nephropathy, while these drugs have effects against hypertension.
Conclusion: This review may provide the constructive information for further drug development in diabetic nephropathy.
Keywords: Diabetic nephropathy, hypertension, renin-angiotensin-aldosterone system, renal function, angiotensin, ACE inhibitor.
Current Diabetes Reviews
Title:Common Drugs for Stabilization of Renal Function in the Progression of Diabetic Nephropathy and Their Relations with Hypertension Therapy
Volume: 14 Issue: 2
Author(s): Yuxuan Wang, Chengcheng Wang, Xiuli Zhang, Harvest F. Gu*Liang Wu*
Affiliation:
- Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, 17176,Sweden
- Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, 210009,China
Keywords: Diabetic nephropathy, hypertension, renin-angiotensin-aldosterone system, renal function, angiotensin, ACE inhibitor.
Abstract: Introduction: Diabetic nephropathy is characterized by hypertension, progressive albuminuria, glomerulosclerosis and declines in glomerular filtration rate leading to end stage renal disease. Although the pathogenesis of diabetic nephropathy is not fully understood, current treatment of the patients with diabetic nephropathy is mainly based upon the control of hyperglycaemia and management of blood pressures.
Background: Several drugs, which are originally developed for hypertension therapy, have been adopted for stabilization of renal function in diabetic nephropathy. In this review, we first discussed the relationships between diabetic nephropathy and hypertension particularly in the renin-angiotensinaldosterone system. We then summarized chemical structures, pharmacological characteristics and clinical studies of the common drugs used for treatment of diabetic nephropathy, while these drugs have effects against hypertension.
Conclusion: This review may provide the constructive information for further drug development in diabetic nephropathy.
Export Options
About this article
Cite this article as:
Wang Yuxuan, Wang Chengcheng, Zhang Xiuli, Gu F. Harvest*, Wu Liang*, Common Drugs for Stabilization of Renal Function in the Progression of Diabetic Nephropathy and Their Relations with Hypertension Therapy, Current Diabetes Reviews 2018; 14 (2) . https://dx.doi.org/10.2174/1573399813666170214112115
DOI https://dx.doi.org/10.2174/1573399813666170214112115 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vildagliptin Restores Renal Myogenic Function and Attenuates Renal Sclerosis Independently of Effects on Blood Glucose or Proteinuria in Zucker Diabetic Fatty Rat
Current Vascular Pharmacology Antioxidants and its Properties as Affected by Extrusion Process: A Review
Recent Patents on Food, Nutrition & Agriculture Metabolic Syndrome and Cardiometabolic Risk Factors
Current Vascular Pharmacology Uric Acid Metabolism in Pre-hypertension and the Metabolic Syndrome
Current Vascular Pharmacology Early Urinary Markers for Diabetic and Other Kidney Diseases
Current Drug Targets Leptin and the Cardiovascular System: A Review
Recent Patents on Cardiovascular Drug Discovery Opportunities for Pharmacotherapy at the Intersection of Metabolic Syndrome and Hemostasis
Current Pharmaceutical Biotechnology The Role of Transforming Growth Factor β1 in the Regulation of Blood Pressure
Current Hypertension Reviews Biochemical Markers in the Prediction of Contrast-induced Acute Kidney Injury
Current Medicinal Chemistry The Effect of Risk Factor Changes on Peripheral Arterial Disease and Cardiovascular Risk
Current Drug Targets - Cardiovascular & Hematological Disorders Mitochondrial genome sequencing in atherosclerosis: what's next?
Current Pharmaceutical Design Histone Deacetylase Inhibitors Target Diabetes via Chromatin Remodeling or as Chemical Chaperones?
Current Diabetes Reviews Transfection of TGF-β shRNA by Using Ultrasound-targeted Microbubble Destruction to Inhibit the Early Adhesion Repair of Rats Wounded Achilles Tendon In vitro and In vivo
Current Gene Therapy New Insight into Urate-Related Mechanism of Cardiovascular Damage
Current Pharmaceutical Design Advances in the Methodologies for the Analysis of Acute Kidney Injury Biomarkers
Recent Patents on Biomarkers Telomere/Telomerase System: A New Target of Statins Pleiotropic Effect?
Current Vascular Pharmacology Metabolomics Analysis for Biomarker Discovery: Advances and Challenges
Current Medicinal Chemistry Prediction of Disease-Related Genes Based on Hybrid Features
Current Proteomics Signal Transduction Therapy of Diabetic Vascular Complication
Current Signal Transduction Therapy Lipid Composition of Cell Membranes and Its Relevance in Type 2 Diabetes Mellitus
Current Diabetes Reviews